ALLIANCE A222004

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Brain, Brain Metastatic, Breast, Breast Metastatic, Carcinoid Metastatic, Cervical Metastatic, Colon Metastatic, Endometrial Metastatic, Esophageal Metastatic, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck Metastatic, Lung, Lung - Non-Small Cell Metastatic, Metastatic Melanoma, Neuroendocrine, Pancreatic Metastatic, Prostate Metastatic, Rectal Metastatic, Renal Metastatic, Skin, Stomach Metastatic

Status:

New, Open

A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

NCT#04939090

Eligible for screening study DCP 001

Site staff should complete the information required on Site Activation Form (Click Here) and submit it to the Alliance Pharmaceutical Affairs Manager at pharmaffairs@alliancenctn.org, along with a copy of the site’s pharmacy or physician license.